As regulatory stakeholders from around the world meet at the 17th International Conference of Drug Regulatory Authorities (ICDRA) in Cape Town, South Africa from 27 November to 2 December 2016 (http://www.icdra.co.za/), an open #preICDRA2016 conference, titled “Patients Are Waiting: How Regulators Collectively Make a Difference” will be convened from the 27-28 November 2016 at the...
Read moreResearch-based pharmaceutical industry contributes to key global health discussions at 69th World Health Assembly New resolutions adopted by the World Health Assembly included rules on relations the World Health Organization can have with the private sector, amongst others; structures for R&D funding and coordination; access to medicines and integrated health services; global sector strategies on...
Read moreThis is just a teaser of the session that took place at 2016 GHF ‘Shaping a sound supply chain ecosystem’ gathered speakers from BMS, IFPW Walgreens Boots Alliance, ICRC and WHO. Moderated by Scrip’s Sukaina Virji. To find out more about the complexities of the pharmaceutical supply chain, to hear what experts think are the...
Read moreThe session that took place at 2016 GHF ‘Shaping a sound supply chain ecosystem’ gathered speakers from BMS, IFPW Walgreens Boots Alliance, ICRC and WHO. Moderated by Scrip’s Sukaina Virji. To find out more about the complexities of the pharmaceutical supply chain, to hear what experts think are the essential elements for robust health policies...
Read moreWHA 69, Item 16.2: Follow-up to the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination Delivered by Mario Ottiglio, Director, Public Affairs, Communications and Global Health Policy, IFPMA Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as...
Read moreWHA 69, Item 11.3 Framework of engagement with non-State actors Delivered by Mario Ottiglio, Director, Public Affairs, Communications and Global Health Policy, IFPMA IFPMA welcomes continued efforts to design a framework allowing WHO to fulfill its leadership role in global health and its mandate by engaging with a varied set of actors, while managing any...
Read moreWHA 69, Item 14.4 Global action plan on antimicrobial resistance Delivered by Nina Grundmann, Associate Manager, Global Health Policy, IFPMA IFPMA commends WHO for presenting options for the establishment of a global development and stewardship framework and for its efforts to increase political awareness, engagement and leadership on AMR with the upcoming High Level Meeting...
Read moreThis blog was originally posted in Diplomatic Courier Since the start of this millennium, we have witnessed many success stories in global health. Death from infectious diseases like malaria and tuberculosis have been cut in half. A child is twice as likely to survive past their fifth birthday than he or she was fifteen year ago....
Read more